Series A - New Haven Pharmaceuticals - Oct 29, 2012 Funding Round Profile - Cointime

Bitcoin $80,197.71 +5.26%
Ethereum $3,214.84 +4.77%
BNB $632.58 +2.72%
Optimism $1.67 +5.73%
Arbitrum $0.64 +7.80%
Solana $210.14 +6.22%
Polygon $0.42 +11.34%
Cosmos $5.44 +15.90%
Avalanche $32.39 +11.97%

Bitcoin $80,197.71 +5.26%
Ethereum $3,214.84 +4.77%
BNB $632.58 +2.72%
Optimism $1.67 +5.73%
Arbitrum $0.64 +7.80%
Solana $210.14 +6.22%
Polygon $0.42 +11.34%
Cosmos $5.44 +15.90%
Avalanche $32.39 +11.97%

New Haven Pharmaceuticals

company

Funding Round

Series A

Money Raised

$ 6.49M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail